BackTempest Therapeutics Overview

Tempest Therapeutics Current Cash

Track Tempest Therapeutics's current cash ($780K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$779000.00
94.54% YoYΔ $-13.50M vs prior year quarter

Peer trimmed avg / median

Loading

Tempest Therapeutics Current Cash History

Loading

Tempest Therapeutics vs. peers: Current Cash Comparison

Loading

Tempest Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tempest Therapeutics (TPST) FAQ

As of the most recent data (June 2026), TPST shows a current cash of $780K. That compares with $14M in the prior-year period — down 94.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TPST's current cash is now $780K (was $14M) — a 94.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Tempest Therapeutics is outperforming or lagging.

Tracking TPST's current cash over time shows whether Tempest Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $780K That compares with $14M in the prior-year period — down 94.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Tempest Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $780K) with ownership activity and broader fundamentals.

Tempest Therapeutics's current cash is $780K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.